Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Chunfeng Li, Audrey Lee, Lilit Grigoryan, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 543-555
Open Access | Times Cited: 312

Showing 1-25 of 312 citing articles:

Innate immune mechanisms of mRNA vaccines
R Verbeke, Michael J. Hogan, Karin Loré, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 215
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 112
Engineering cytokine therapeutics
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 110
Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19
Vaughn D. Craddock, Aatish Mahajan, Leslie Spikes, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 87
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
Nature Microbiology (2023) Vol. 8, Iss. 4, pp. 569-580
Open Access | Times Cited: 84
Targeted modulation of immune cells and tissues using engineered biomaterials
Parisa Yousefpour, Kaiyuan Ni, Darrell J. Irvine
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 107-124
Open Access | Times Cited: 80
Circular RNA vaccine induces potent T cell responses
Laura Amaya, Lilit Grigoryan, Zhijian Li, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 20
Open Access | Times Cited: 73
Making innate sense of mRNA vaccine adjuvanticity
Kouji Kobiyama, Ken J. Ishii
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 474-476
Open Access | Times Cited: 71
Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 70
Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 67
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 64
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
Jennifer Connors, David Joyner, Nathan Mege, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 53
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 281-300
Closed Access | Times Cited: 52
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 50
STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2
Yuebao Zhang, Jinyue Yan, Xucheng Hou, et al.
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2593-2600
Open Access | Times Cited: 43
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance
Audrey Lee, Katharine Floyd, Shengyang Wu, et al.
Nature Immunology (2023) Vol. 25, Iss. 1, pp. 41-53
Closed Access | Times Cited: 41
Recent advances in nanoparticulate RNA delivery systems
Jacob Witten, Yizong Hu, Róbert Langer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 36
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways
Ying Wang, Sirui Li, Mengying Hu, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 6, pp. 856-866
Closed Access | Times Cited: 22
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, Sérgio Scalzo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Vaccine design via antigen reorientation
Duo Xu, Joshua Carter, Chunfeng Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 8, pp. 1012-1021
Open Access | Times Cited: 15
Vaccine adjuvants: Tailoring innate recognition to send the right message
Ed C. Lavelle, Craig P. McEntee
Immunity (2024) Vol. 57, Iss. 4, pp. 772-789
Open Access | Times Cited: 14
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
Paula David, Saptarshi Sinha, Khizer Iqbal, et al.
EBioMedicine (2024) Vol. 104, pp. 105136-105136
Open Access | Times Cited: 14
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans
Mario Cortese, Thomas Hagan, Nadine Rouphael, et al.
Nature Immunology (2025) Vol. 26, Iss. 1, pp. 116-130
Closed Access | Times Cited: 1
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
Maureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1105-1117
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top